Product
name: Exendin (9–39)
Synonyms:
GLP-1 receptor agonist,
Sequence:
DLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS
Quantity: 5mg
Purity: 95% by
HPLC
Counter
ion: Trifluoacetate
Format: Lyophilized
powder
Description: Exendin-4 (Ex-4), a
long-acting agonist of glucagon-like peptide-1 receptor, is a novel
anti-diabetic drug that prevents ¥â-cells against various toxicities. The GLP-1
receptor antagonist, exendin (9–39), antagonised emesis and c-Fos expression in
the brainstem and the paraventricular hypothalamus induced by the
chemotherapeutic drug cisplatin (30 mg/kg, i.p.; p < 0.05), but not the
emesis induced by nicotine (5 mg/kg, s.c.; p > 0.05), or copper sulphate
pentahydrate (120 mg/kg, p.o.; p > 0.05).
Uniprot
ID:
Usage: For
Scientific Research Use Only, Not for Human Use.
Reference:
Neuropharmacology, Volume 83, August 2014, Pages
71-78